Literature DB >> 22934728

BRCA carriers, prophylactic salpingo-oophorectomy and menopause: clinical management considerations and recommendations.

Amy Finch1, Gareth Evans, Steven A Narod.   

Abstract

Women who inherit a mutation in either the BRCA1 or BRCA2 gene have greatly elevated lifetime risks of ovarian cancer, fallopian tube cancer and breast cancer. Preventive surgical removal of the ovaries and fallopian tubes (salpingo-oophorectomy) is recommended to these women, often prior to natural menopause, to prevent cancer. The ensuing hormone deprivation may impact on health and quality of life. Most of these women experience menopausal symptoms shortly after surgery; however, there may also be longer term consequences that are less well understood. In this review, we highlight recent studies that examine the implications of salpingo-oophorectomy on health and quality of life in BRCA-positive women and we discuss the care of women following prophylactic surgery.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22934728     DOI: 10.2217/whe.12.41

Source DB:  PubMed          Journal:  Womens Health (Lond)        ISSN: 1745-5057


  28 in total

Review 1.  It's Totally Tubular....Riding The New Wave of Ovarian Cancer Research.

Authors:  Ruth Perets; Ronny Drapkin
Journal:  Cancer Res       Date:  2015-12-15       Impact factor: 12.701

2.  Bone loss after oophorectomy among high-risk women: an NRG oncology/gynecologic oncology group study.

Authors:  Elizabeth A Hibler; James Kauderer; Mark H Greene; Gustavo C Rodriguez; David S Alberts
Journal:  Menopause       Date:  2016-11       Impact factor: 2.953

3.  Impact of oophorectomy on cancer incidence and mortality in women with a BRCA1 or BRCA2 mutation.

Authors:  Amy P M Finch; Jan Lubinski; Pål Møller; Christian F Singer; Beth Karlan; Leigha Senter; Barry Rosen; Lovise Maehle; Parviz Ghadirian; Cezary Cybulski; Tomasz Huzarski; Andrea Eisen; William D Foulkes; Charmaine Kim-Sing; Peter Ainsworth; Nadine Tung; Henry T Lynch; Susan Neuhausen; Kelly A Metcalfe; Islay Thompson; Joan Murphy; Ping Sun; Steven A Narod
Journal:  J Clin Oncol       Date:  2014-02-24       Impact factor: 44.544

4.  A Psychological Perspective on Factors Predicting Prophylactic Salpingo-Oophorectomy in a Sample of Italian Women from the General Population. Results from a Hypothetical Study in the Context of BRCA Mutations.

Authors:  Teresa Gavaruzzi; Alessandra Tasso; Marzena Franiuk; Liliana Varesco; Lorella Lotto
Journal:  J Genet Couns       Date:  2017-03-23       Impact factor: 2.537

Review 5.  Müllerian intra-abdominal carcinomatosis in hereditary breast ovarian cancer syndrome: implications for risk-reducing surgery.

Authors:  Murray Joseph Casey; Agnes B Colanta
Journal:  Fam Cancer       Date:  2016-07       Impact factor: 2.375

6.  Ovarian Aging in Women With BRCA Germline Mutations.

Authors:  Wayne Lin; Shiny Titus; Fred Moy; Elizabeth S Ginsburg; Kutluk Oktay
Journal:  J Clin Endocrinol Metab       Date:  2017-10-01       Impact factor: 5.958

7.  Reducing the Risk of Gynecologic Cancer in Hereditary Breast Ovarian Cancer Syndrome Mutation Carriers: Moral Dilemmas and the Principle of Double Effect.

Authors:  Murray Joseph Casey; Todd A Salzman
Journal:  Linacre Q       Date:  2018-07-20

Review 8.  Clinical significance of microsatellite instability in colorectal cancer.

Authors:  Matthias Kloor; Laura Staffa; Aysel Ahadova; Magnus von Knebel Doeberitz
Journal:  Langenbecks Arch Surg       Date:  2013-09-19       Impact factor: 3.445

9.  Bilateral Oophorectomy and Breast Cancer Risk in BRCA1 and BRCA2 Mutation Carriers.

Authors:  Joanne Kotsopoulos; Tomasz Huzarski; Jacek Gronwald; Christian F Singer; Pal Moller; Henry T Lynch; Susan Armel; Beth Karlan; William D Foulkes; Susan L Neuhausen; Leigha Senter; Nadine Tung; Jeffrey N Weitzel; Andrea Eisen; Kelly Metcalfe; Charis Eng; Tuya Pal; Gareth Evans; Ping Sun; Jan Lubinski; Steven A Narod
Journal:  J Natl Cancer Inst       Date:  2016-09-06       Impact factor: 13.506

10.  Rescue of wild-type E-cadherin expression from nonsense-mutated cancer cells by a suppressor-tRNA.

Authors:  Renata Bordeira-Carriço; Daniel Ferreira; Denisa D Mateus; Hugo Pinheiro; Ana Paula Pêgo; Manuel A S Santos; Carla Oliveira
Journal:  Eur J Hum Genet       Date:  2014-01-15       Impact factor: 4.246

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.